BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25199942)

  • 1. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
    Lampl C; Likar R
    Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metamizole (Dipyrone) and the Liver: A Review of the Literature.
    Lutz M
    J Clin Pharmacol; 2019 Nov; 59(11):1433-1442. PubMed ID: 31433499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.
    Konijnenbelt-Peters J; van der Heijden C; Ekhart C; Bos J; Bruhn J; Kramers C
    Pain Pract; 2017 Mar; 17(3):402-408. PubMed ID: 27346584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Agranulocytosis in a patient treated with metamizole and clopidogrel].
    Kummer O; Haschke M; Tuchscherer D; Lampert M; Martius F; Krähenbühl S
    Praxis (Bern 1994); 2006 Nov; 95(45):1743-5; quiz 1746-7. PubMed ID: 17205929
    [No Abstract]   [Full Text] [Related]  

  • 5. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
    Işık M; Kaya Z; Belen FB; Aktaş AT; Tezer H; Gürsel T
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
    Hedenmalm K; Spigset O
    Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose.
    Allgaier R; Kandulski A; Gülow K; Maier L; Müller M; Tews HC
    Drugs R D; 2023 Jun; 23(2):93-98. PubMed ID: 36988798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of metamizole sodium-induced agranulocytosis in Poland.
    Maj S; Lis Y
    J Int Med Res; 2002; 30(5):488-95. PubMed ID: 12449518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metamizol: current status in Dutch practice].
    van Diepen ATN; Simons P; Bos JM; Kramers C
    Ned Tijdschr Geneeskd; 2022 Jan; 166():. PubMed ID: 35138735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic use of metamizole: not so safe after all?
    Vuik FE; Koehestanie P; Herbers AH; Terhaar Sive Droste JS
    Neth J Med; 2017 Mar; 75(2):81-83. PubMed ID: 28276328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].
    Stamer UM; Gundert-Remy U; Biermann E; Erlenwein J; Meiβner W; Wirz S; Stammschulte T
    Schmerz; 2017 Feb; 31(1):5-13. PubMed ID: 27766404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recall of metamizole from the market in countries with modern pharmacotherapy].
    Mihajlović G
    Srp Arh Celok Lek; 1996; 124(1-2):44-6. PubMed ID: 9102814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
    Hoffmann F; Bantel C; Jobski K
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of drug-induced agranulocytosis with granulocyte colony stimulating factor (G-CSF) in a surgical intensive care unit].
    Huss B; Bogosyan S; Müller E; Götz E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):529-30. PubMed ID: 9019189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmasking of Metamizole-induced Liver Injury by Simult aneous Development of Characteristic Agranulocytosis.
    Lutz M; Grünewald I; Lenze F; Heinzow H; Ullerich H; Kabar I; Schmidt HH; Tepasse PR
    Curr Drug Saf; 2023; 18(3):404-412. PubMed ID: 35670337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
    Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Agranulocytosis induced by metamizole and its management with granulocyte growth factor].
    Celeketić D; Trpković A; Cvetković Z
    Vojnosanit Pregl; 2005 Jan; 62(1):79-82. PubMed ID: 15715354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data.
    Klose S; Pflock R; König IR; Linder R; Schwaninger M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyrone (metamizole) use in the United States: a lethal tango?
    Moorman J
    South Med J; 2006 Sep; 99(9):916. PubMed ID: 17004522
    [No Abstract]   [Full Text] [Related]  

  • 20. [Severe thrombocytopenia and agranulocytosis associated with metamizole].
    Fernández García PL; Ibáñez Camacho MF; López Pérez E
    Med Clin (Barc); 2016 Oct; 147(8):e43-e44. PubMed ID: 27450174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.